November 17, 2020 A class action alleges Alibaba Group investors were harmed financially when fintech affiliate Ant Group's historic IPO was suspended.
October 15, 2020 A class action claims Royal Caribbean harmed investors by issuing between Feb. and Mar. 2020 false and/or misleading statements concerning sagging cruise bookings outside of China and RC's ability to contain the spread of coronavirus.
October 2, 2020 Peabody Energy Corp. materially misled stockholders with regard to the safety practices and production output at its most profitable coal mine, a lawsuit claims.
September 24, 2020 Nikola Corporation faces a securities class action in the wake of a short seller's report characterizing the hydrogen-electric vehicle maker as "an intricate fraud."
August 28, 2020 A proposed class action claims Fastly, Inc. failed to disclose to investors that its largest customer was the Chinese company behind the controversial TikTok app.
August 28, 2020 Blink faces a class action that claims investors were harmed financially after it was revealed the company misrepresented its electric car charging network.
August 26, 2020 A class action alleges Vaxart and Armistice Capital participated in a "pump and dump" scheme whereby they boosted stock prices on the back of multiple false COVID-19 vaccine proclamations.
August 20, 2020 Genius Brands faces a lawsuit in which an investor claims stockholders have been harmed financially by the company's misstatements and a resulting drop in stock price.
August 17, 2020 Eastman Kodak Co. and its CEO and CFO face a class action after a $765M federal loan to produce COVID-19 drug materials was paused over concerns of alleged insider trading.
July 31, 2020 An Intel investor claims a drop in stock price is linked to the company’s failure to disclose impending production delays for its 7-nanometer CPU technology.
July 10, 2020 Wirecard AG, former execs and auditor Ernst & Young face a securities class action in the wake of the global payment processor's collapse.
June 23, 2020 Chembio Diagnostics faces a class action centered on the FDA's revocation of an emergency use authorization for the company's COVID-19 antibody test.